ANN ARBOR - The 2006 MichBio Expo on Wednesday announced two of its keynote speakers for this year's conference to be held in Grand Rapids this October ? David Duncan, the co host of NPR's Biotech Nation, and David Van Andel, the CEO of the Van Andel Institute, a biomedical R&D center in Grand Rapids.
DETROIT ? Allied Minds, a pre-seed investment corporation specializing in early stage university business ventures, has partnered with Wayne State University to create GliaGen, which will specialize in novel diagnostic and therapeutic technologies specifically tailored to treat neurodegenerative diseases. GliaGen has exclusively secured platform technology developed by Drs. Leon Carlock and Maria Cypher at the
DETROIT ? Tissue bank Asterand is offering medical researchers the ability to obtain gene expression data through its new online gateway called Xpressway, the result of almost ten years of work by an Asterand team that specializes in human tissue-based research. Xpressway will help medical researchers understand which genes are expressed in different parts of
GRAND RAPIDS ? A New Jersey-based pharmaceutical R&D organization will spend $200,000 to partner with Michigan's Core Technology Alliance to develop four pilot projects in Michigan to help develop new drugs, the first out of state pharmaceutical company recruited by the former Michigan Life Sciences Corridor. Schering-Plough Research Institute, the research and development division of
ANN ARBOR ? University of Michigan technology spin out NanoBio Corp. will get a $30 million investment from Perseus, a private equity fund management company. The money will be used to support NanoBio's expanding clinical pipeline. NanoBio has developed multiple topical anti-infective products and vaccine candidates derived from its NanoStat technology. The company's lead product
LANSING ? MichBio, the state Life Sciences trade association, has been chosen to coordinate commercialization of life sciences products and services, assist start-up companies and develop marketing programs in hopes of giving the very young Michigan life sciences industry an economic shot in the arm. MichBio?s mandate under the 21st Century Jobs Fund Life Sciences
ANN ARBOR - QuatRx Pharmaceuticals Co. announced unexpectedly Monday that it has withdrawn its Initial Public Offering registration with the Securities and Exchange Commission because of poor market conditions. In a statement, QuatRx Chief Financial Officer Gary Onn said the market has not been kind to life science companies and QuatRx didn?t think it could
ALLEGAN - The Perrigo Company, the world's largest manufacturer of over-the-counter-drugs, has promoted its former controller to the post of executive vice president and chief financial officer. Judy Brown succeeds Douglas Schrank, who retired June 30. Brown, who joined Perrigo in September 2004, has overseen the various departments within finance, including Investor Relations, Treasury and
ANN ARBOR - MichBio, Michigan?s life science trade association, announced it has scheduled a Student Life Science Career Day October 10 in Grand Rapids during the first day of the MichBio Expo 2006. Grand Valley State University and the Van Andel Institute, in partnership with MichBio, will host the career day. This event is for
ANN ARBOR ? Stephen Rapundalo, executive director of MichBio, the state's life sciences industry association, said Thursday that his organization opposes efforts in Michigan to repeal of tort and product liability legislation because it could jeopardize access to new prescription drugs developed by MichBio members, like Pfizer. Rapundalo joined patients, health care providers, manufacturers, pharmaceutical